# Canopy Growth’s Apollo Clinics Named Top Medical Cannabis Provider by Toronto Star Readers > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medical-cannabis-provider-recognition-apollo-clinics/ > **Published:** 2026-03-31T12:08:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:34:10-04:00 > **Clinical Summary:** Apollo Clinics earn medical cannabis provider recognition from Toronto Star readers, highlighting patient satisfaction and healthcare quality in cannabis services. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Healthcare QualityPatient Care[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Clinical StandardsProvider Selection Why This Matters Patient recognition of cannabis clinics reflects growing acceptance and utilization of [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) services, but reader polls don’t evaluate clinical quality metrics that matter for patient outcomes. This highlights the need for evidence-based standards in cannabis healthcare delivery. Clinical Summary Canopy Growth’s Apollo Clinics received a patient choice award from Toronto Star readers, indicating consumer satisfaction with their medical cannabis services. This recognition reflects the maturation of the cannabis healthcare sector in Canada, where medical cannabis has been federally legal since 2001. However, popularity awards don’t assess clinical outcomes, evidence-based protocols, or physician training standards that determine quality of care. Dr. Caplan’s Take “Patient satisfaction matters, but I’d want to see data on clinical protocols, physician [cannabis education](https://cedclinic.com/unlock-healing-potential-cannabis-audiobook/), and patient outcomes before recommending any cannabis clinic. Awards based on reader polls tell us about marketing reach, not medical quality.” Clinical Perspective 🧠 When selecting cannabis healthcare providers, patients should prioritize clinics with board-certified physicians who have formal [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) training, evidence-based dosing protocols, and comprehensive follow-up care. Consumer awards can indicate accessibility and service quality but shouldn’t substitute for evaluating clinical expertise and patient outcome data. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Canopy%20Growth%27s%20Apollo%20Clinics%20Named%20Top%20Medical%20Cannabis%20Provider%20by%20Toronto%20St...%20%40drcaplan&url=https%3A//www.theglobeandmail.com/investing/markets/stocks/CGC/pressreleases/1063133/canopy-growths-apollo-clinics-named-top-medical-cannabis-provider-by-toronto-star-readers/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.theglobeandmail.com/investing/markets/stocks/CGC/pressreleases/1063133/canopy-growths-apollo-clinics-named-top-medical-cannabis-provider-by-toronto-star-readers/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Canopy%20Growth%27s%20Apollo%20Clinics%20Named%20Top%20Medical%20Cannabis%20Provider%20by%20Toronto%20St...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.theglobeandmail.com/investing/markets/stocks/CGC/pressreleases/1063133/canopy-growths-apollo-clinics-named-top-medical-cannabis-provider-by-toronto-star-readers/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.theglobeandmail.com/investing/markets/stocks/CGC/pressreleases/1063133/canopy-growths-apollo-clinics-named-top-medical-cannabis-provider-by-toronto-star-readers/](https://www.theglobeandmail.com/investing/markets/stocks/CGC/pressreleases/1063133/canopy-growths-apollo-clinics-named-top-medical-cannabis-provider-by-toronto-star-readers/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What areas of healthcare does this cannabis news cover?](#What_areas_of_healthcare_does_this_cannabis_news_cover) - [Why is this cannabis news considered clinically significant?](#Why_is_this_cannabis_news_considered_clinically_significant) - [What type of medical professionals should be aware of this news?](#What_type_of_medical_professionals_should_be_aware_of_this_news) - [Is this a new development in medical cannabis?](#Is_this_a_new_development_in_medical_cannabis) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #76, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What areas of healthcare does this cannabis news cover? The article focuses on healthcare quality, patient care, medical cannabis, and clinical standards. These tags indicate the news relates to improving patient outcomes and establishing proper medical cannabis protocols. #### Why is this cannabis news considered clinically significant? The “Notable Clinical Interest” designation means this represents emerging findings or policy developments in medical cannabis. Healthcare providers should pay attention as these developments could impact patient care standards and treatment protocols. #### What type of medical professionals should be aware of this news? Healthcare providers involved in patient care, particularly those working with medical cannabis patients, should monitor this development. The clinical standards focus suggests it’s relevant for practitioners establishing or following cannabis treatment protocols. #### Is this a new development in medical cannabis? Yes, the article is marked as “New” indicating recent developments in the field. The clinical relevance rating suggests these are emerging findings that warrant attention from the medical community. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Canopy Growth’s Apollo Clinics Named Top Medical Cannabis Provider by Toronto Star Readers”, “url”: “https://www.theglobeandmail.com/investing/markets/stocks/CGC/pressreleases/1063133/canopy-growths-apollo-clinics-named-top-medical-cannabis-provider-by-toronto-star-readers/”, “datePublished”: “2026-03-31T13:50:47Z”, “about”: “canopy growth s apollo clinics named”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Approved medical marijuana cards up 62% year over year – Dakota News Now](https://cedclinic.com/approved-medical-marijuana-patient-growth-62-percent/) Explore the significant increase in approved [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) cards, reflecting growing patient access and acceptance of medical cannabis. [Learn More](https://cedclinic.com/approved-medical-marijuana-patient-growth-62-percent/) [New medical cannabis clinic opens in the Highlands – WAVE 3](https://cedclinic.com/new-medical-cannabis-clinic-opens-highlands/) Discover the latest developments in medical cannabis care with the opening of a new clinic focused on patient-centered services. [Read Article](https://cedclinic.com/new-medical-cannabis-clinic-opens-highlands/) [First-of-its-Kind Medical Cannabis Education Platform for Clinicians and Patients Now Open](https://cedclinic.com/medical-cannabis-education-platform-clinicians-patients/) Access innovative educational resources designed to improve clinical standards and patient outcomes in [medical cannabis treatment](https://cedclinic.com/medical-cannabis-eligibility-book-appointment/). [Explore Platform](https://cedclinic.com/medical-cannabis-education-platform-clinicians-patients/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).